Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims

INTRODUCTION: To analyze healthcare resource utilization (HRU) and healthcare costs in men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population. METHODS: A published claims-based algorithm was used to identify men with mCRPC in the fee-for-service Medicare popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedland, Stephen J., Davis, Matthew R., Epstein, Andrew J., Arondekar, Bhakti, Ivanova, Jasmina I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500004/
https://www.ncbi.nlm.nih.gov/pubmed/37531024
http://dx.doi.org/10.1007/s12325-023-02572-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500004/
https://www.ncbi.nlm.nih.gov/pubmed/37531024
http://dx.doi.org/10.1007/s12325-023-02572-4

Ejemplares similares